Cover Image
市場調查報告書

電子臨床實驗解決方案的全球市場:成長率、趨勢、未來預測

Global E-Clinical Solutions Market - Segmented by Product, Deployment Mode, End User, and Region - Growth, Trends, and Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 393727
出版日期 內容資訊 英文 116 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
電子臨床實驗解決方案的全球市場:成長率、趨勢、未來預測 Global E-Clinical Solutions Market - Segmented by Product, Deployment Mode, End User, and Region - Growth, Trends, and Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 116 Pages
簡介

本報告提供全球電子臨床實驗解決方案 (e臨床解決方案) - 臨床實驗相關的資訊收集、共享、保存解決方案 - 的市場相關分析,技術概要和主要的按推動及阻礙市場要素,各產品種類、各引進方式、各終端用戶、各地區的市場趨勢預測,主要供應商簡介、市場佔有率,近來的資本交易的動向,今後的市場成長機會等調查、考察。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 市場動態與趨勢

  • 市場概要
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 產業的價值鏈分析
  • 產業的向心力:波特的五力分析

第5章 技術概要

  • 技術現況
  • 近幾年的開發趨勢

第6章 電子臨床實驗解決方案:各產品種類的市場區隔

  • CDMS (臨床資料管理系統)
  • CTMS (臨床實驗管理系統)
  • 隨機、臨床消耗品管理
  • EDC (電子資料理解)
  • eCOA (電子的臨床療效評估)
  • ePRO (電子的病人報告結果)
  • 臨床分析平台
  • 臨床實驗資料整合平台
  • 其他

第7章 電子臨床實驗解決方案:各發展方式的市場區隔

  • Web基礎、託管、解決方案
  • 雲端基礎解決方案
  • 授權式 (企業用) 解決方案

第8章 電子臨床實驗解決方案:各終端用戶的市場區隔

  • 生物科技
  • 醫療設備廠商
  • 醫療機關
  • 製藥企業
  • CRO (醫藥品臨床研究委外機構)
  • 其他

第9章 電子臨床實驗解決方案:各地區的市場區隔

  • 北美
  • 歐洲
  • 亞太地區
  • 中東
  • 其他的國家 (RoW)

第10章 主要供應商簡介

  • Oracle Corporation
  • BioClinicia
  • PAREXEL International Corporation
  • OmniComm Systems
  • ERT
  • Datatrak International Inc.
  • PHT Corporation
  • eClinical Solutions, Inc.
  • Medidata Solutions, Inc
  • Merge Healthcare Incorporated
  • CRF Health

第11章 各供應商的市場佔有率

第12章 投資者預測

  • 投資方案
  • 近幾年的企業合併、收購 (M&A)

第13章 電子臨床實驗解決方案的未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 33388

Description

In 2017, the global eclinical solutions market was valued at USD 4.48 billion and is expected to reach a value of USD 9.26 billion by 2023, registering a CAGR of 12.86%, during 2018-2023 (the forecast period). According to the National Institute of Health's Clinical Trials registry in the United States, the number of clinical trials underway each year has been increasing consistently. In the last five years, over 75,000 federally and privately supported trials have been registered. Clinical testing of new drugs is an expensive, a complex and lengthy process. These aspects are fueling the need for electronic data capture and remote data entries, thus, augmenting the growth of the global eclinical solutions market over the forecast period. In addition to the reduction of time and cost, eclinical solutions are also improving data management and integrating data from different trials for clearer analysis. The percentage of aged population (>65 years) is increasing gradually, which is a strong indicator for the market growth. This can be attributed to the fact that elderly population accounts for the major share in clinical homes.

Enormous Data Capture From The Healthcare Industry

The sheer volume of the healthcare data is growing at an astronomical rate: In 2013, around 153 exabytes (one exabyte = one billion gigabytes) were produced and an estimated 2,314 exabytes are expected to be produced by 2020, translating to an overall rate of increase of at least 48% annually. This growth in the amount of data can be attributed to the rising popularity of wearable devices, such as pedometers and heart-rate monitors. It is estimated that the health and fitness technology have seen a record sales in 2017, with 35 million units sold in US. With the advent of innovative solutions in the market, consumers are likely to continue experimenting these and adopt the new iterations of wearables that link the data produced directly to medical professionals, including doctors and researchers. This explosion of data is expected to drive the market but in order to achieve that, companies must have adequate access to Internet and most of the developing companies are still lagging behind, in terms of robust internet infrastructure systems. However, rapid adoption of the big data and other business intelligence methodologies are likely to ease the process of enormous clinical trials data-flow, mounting from the healthcare industry with the help of eClinical solutions.

Clinical Data Management Systems (CDMS) To Hold The Largest Market Share During Forecast Period

CDMS is fueling the reduction of time required for the clinical research, from drug development to marketing phase, along with the generation of reliable and statistically sound data. The need for faster commercialization of a product, in order to sustain the market competition, is boosting the CDMS market in eClinical solutions. In addition, it is a mandate for companies to submit the data, electronically, to meet the expectations and set standards for data quality. This factor is expected to drive the CDMS market during the forecast period.

Technological advancements, bringing about the gradual shift from the paper-based to the electronic systems of data management and advanced developments on the data analytical front, are positively impacting the CDM process. The systems are being developed to strike a balance between the expectations and constraints in the existing systems, driven by technological developments and business demands. This factor is boosting the market of CDMS, across the globe.

In 2018, North America to Hold the Largest Share in the Market

In 2017, North America, followed by Europe, was the largest regional segment in the global eClinical solutions market. Factors, such as increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines when compared to developed nations, the availability of a large patient base and faster patient recruitment for clinical trials, and increasing number of pharmaceutical companies and CROs, are stimulating the eClinical solutions market growth in the region. The US government is reported to spend more on the healthcare industry than any other nation across the globe; the country spends around USD 10,348 per person, which amounts to nearly 18% of the GDP. The value is about eight percentage points above the average of the industrialized member nations of the Organization for Economic Co-Operation and Development.

The key players in this market include: Oracle Corporation, BioClinicia Inc., PAREXEL International Corporation, OmniComm Systems, Eresearchtechnology, Inc., Datatrak International, Inc., HT Corporation, eClinical Solutions, Inc., Medidata Solutions, Inc., Merge Healthcare Incorporated and CRF Health.

Key Developments In The Market

December 2017- PAREXEL International Corporation introduced the Perceptive Cloud to the life sciences industry, as a part of the organization's recent alliance with Microsoft Corp, which provides cloud infrastructure built on Microsoft Azure.

November 2017 - Bioclinica, Inc. launched the Bioclinica Clinical Adjudication, which enables the independent adjudication of clinical events in conformance with the regulatory requirements governing clinical trials within all therapeutic areas, including cardiac studies and for Major Adverse Cardiac Events (MACE) committees.

Reasons To Purchase This Report

To know how the rise in data generated and support by the government are helping the market growth.

To analyze various market perspectives, with the help of Porter's five forces analysis.

To know which of the solution types is witnessing the highest adoption rate within the industry.

To know which of the regions is expected to witness the fastest growth rate during the forecast period.

To understand the SWOT analysis for the key players and a detailed study of their current strategic interests and key financial performance indicators.

Three months analyst support, along with the Market Estimate sheet (in excel).

Customization of the Report

This report can be customized to meet your requirements.

Table of Contents

1. Introduction

  • 1.1 Key Deliverables of the Study
  • 1.2 Study Assumptions
  • 1.3 Market Definition
  • 1.4 Key Findings of the Study

2. Research Approach and Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Market Overview
  • 4.2 Factors Driving the Market
    • 4.2.1 Enormous Data Mounting from Healthcare Industry
    • 4.2.2 Rising Number of Clinical Trials
    • 4.2.3 Government Emphasis on Clinical Research
  • 4.3 Factors Challenging the Market
    • 4.3.1 Lack of Awareness and Infrastructure in Developing Countries
    • 4.3.2 High Implementation Costs
  • 4.4 Industry Value Chain Analysis
  • 4.5 Industry Attractiveness- Porter's Five Forces Analysis
    • 4.5.1 Bargaining Power of Suppliers
    • 4.5.2 Bargaining Power of Consumers
    • 4.5.3 Threat of New Entrants
    • 4.5.4 Threat of Substitute Products or Services
    • 4.5.5 Competitive Rivalry among Existing Competitors

5. Global eClinical Solutions Market Segmentation

  • 5.1 By Product Type
    • 5.1.1 Clinical Data Management Systems (CDMS)
    • 5.1.2 Clinical Trial Management Systems (CTMS)
    • 5.1.3 Randomization and Trial Supply Management
    • 5.1.4 Electronic Data Capture (EDC)
    • 5.1.5 Electronic Clinical Outcome Assessments (eCOA) & Electronic Patient-Reported Outcomes (ePRO)
    • 5.1.6 Others(Clinical Data Integration & Analytics Platform)
  • 5.2 By Deployment Mode
    • 5.2.1 Web-based hosted eClinical solutions
    • 5.2.2 Cloud-based eClinical solutions
    • 5.2.3 Licensed Enterprise (On-premise)
  • 5.3 By End Users
    • 5.3.1 Pharmaceutical
    • 5.3.2 Contract Research Organizations (CROs)
    • 5.3.3 Hospitals
    • 5.3.4 Others (Biopharma)
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.2 Europe
    • 5.4.3 Asia-Pacific
    • 5.4.4 Latin America
    • 5.4.5 Middle East & Africa

6. Competitive Intelligence- Company Profiles

  • 6.1 Oracle Corporation
  • 6.2 BioClinicia Inc.
  • 6.3 PAREXEL International Corporation
  • 6.4 OmniComm Systems
  • 6.5 Eresearchtechnology Inc.
  • 6.6 Datatrak International Inc.
  • 6.7 HT Corporation
  • 6.8 eClinical Solutions, Inc.
  • 6.9 Medidata Solutions, Inc.
  • 6.10 Merge Healthcare Incorporated
  • 6.11 CRF Health, Inc.

7. Investment Analysis

8. Future of the eClinical Solutions Market

Back to Top